Peer-influenced content. Sources you trust. No registration required. This is HCN.

American Journal of Hematology

The American Journal of Hematology is devoted to the coverage of blood diseases in humans and in animal models of human disease. We publish research on non-malignant and malignant hematological diseases, including clinical and basic studies in leukemia, hemostasis and thrombosis, immunology, blood banking, and stem cell biology. With fast turnaround times and personalized feedback from experts in the field, we provide a friendly submissions process that works collaboratively across hematology so every paper has a home.

The American Journal of Hematology provides broad coverage of experimental and clinical features of blood diseases in humans and in animal models of human disease. The journal publishes original contributions in non-malignant and malignant hematological diseases including clinical and basic studies in hemostasis and thrombosis, immunology, blood banking, and stem cell biology. Clinical translational reports describing novel therapeutic approaches to diagnosis and treatment of hematological diseases are welcomed and encouraged. The journal includes regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, letters and correspondence.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form